Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Keywords

Medicine, Internal medicine, Diabetes mellitus, Proportional hazards model, Hazard ratio

References

• Is hyperglycemia associated with cardiovascular disease? The Framingham Study.Daniel J. Elazar — 1991
• Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later.Eveline Eschwège, Richard Jl, N Thibult — 1985
• Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studiesJohan G. Eriksson, Pekka Jousilahti, Jaana Lindström — 1999
• Cancer Incidence in Five ContinentsRichard Doll, C. S. Muir, John A. H. Waterhouse — 1970
• Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women.WEN-HARN PAN, LUCILA B. CEDRES, Kiang Liu — 1986
• Mortality among diabetics in a national sample.Joel C. Kleinman, Richard P. Donahue, Maureen I Harris — 1988
• The high risk of death by alcohol related diseases in subjects diagnosed as diabetic and impaired glucose tolerant: the Paris Prospective Study after 15 years of follow-up.Beverley Balkau, É. Eschwège, Pierre Ducimetère — 1991
• Intra- and interindividual variability of glucose tolerance in an elderly population.Edith J. M. Feskens — 1991
• Non-cardiovascular disease mortality and diabetes mellitus.Beverley Balkau, Marja Pyörälä, Martin Shipley — 1997
• Asymptomatic hyperglycemia and coronary heart disease in middle-aged men in two employed populations in Chicago.Rose Stamler, Jeremiah Stamler, Howard A. Lindberg — 1979
• Glucose tolerance and coronary heart disease: Helsinki policemen study.Kalevi Pyörälà, Eero Savolainen, E. Lehtovirta — 1979
• Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortalityJ.E. Shaw, Allison Hodge, Maximilian de Courten — 1999
• Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention TrialJeremiah Stamler, Olga Vaccaro, James D. Neaton — 1993
• Relationship of Postload Plasma Glucose to Mortality With 19-Yr Follow-Up. Comparison of one versus two plasma glucose measurements in the Chicago Peoples Gas Company StudyOlga Vaccaro, Karen Ruth, Jeremiah Stamler — 1992
• Fasting Blood Glucose and Risk of Coronary Heart Disease, Stroke, and All‐cause Mortality: A 17‐year Follow‐up Study of Men Born in 1913L.‐O. Ohlson, Kurt Svärdsudd, Lennart Welin — 1986
• Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study.Annika Rosengren, Lennart Welin, A. Tsipogianni — 1989
• Undiagnosed NIDDM: Clinical and Public Health IssuesMaureen I Harris — 1993
• Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.Jørgen Vildershøj Bjørnholt, Gunnar Erikssen, E. Aaser — 1999
• Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status.Beverley Balkau, E Eschwège, L Papoz — 1993
• Abnormal Blood Glucose and Coronary Heart Disease: The Puerto Rico Heart Health ProgramM Cruz-Vidal, M Palmieri, Raúl Costas — 1983

Cited by

• Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran Lipid and Glucose StudyMohammadreza Bozorgmanesh, Farzad Hadaegh, Farhad Sheikholeslami — 2011
• Diabetes and Cardiovascular Disease: Original Insights from the Framingham Heart StudyMohammad Qazi, Shaista Malik — 2013
• NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.D. G. Lance, A. T. Nettles — 2003
• Insulin glulisine provides improved glycemic control in patients with type 2 diabetes.託子 岩田 — 2004
• Dose-response effects of exercise on abdominal obesity and risk factors for cardiovascular disease in adults: study rationale, design and methods.Robert Ross, Robert Hudson, Andrew G. Day — 2013
• High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiographyAgustín García Moreno — 2006
• Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL thresholdR.M. Fryer, E.R. Ebersole, P.B. Henault — 2007
• Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adultsS. Bouma, D. Vethaak, P.L. Meininger — 2007
• Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease.Pancrazio Maria Conte, M. Felici — 2007
• Glucose tolerance in pregnancy and the long-term risk of cardiovascular disease.Juliane Sander — 2009
• Pre-Mixed Rapid-Acting Insulin 50/50 Analogue Twice Daily is Useful Not Only for Controlling Post-Prandial Blood Glucose, but Also for Stabilizing the Diurnal Variation of Blood Glucose Levels: Switching from Pre-Mixed Insulin 70/30 or 75/25 to Pre-Mixed Insulin 50/50Tita Valencia — 2010
• [Associated factors of impaired fasting glucose in some Korean rural adults].Sergi Reboredo — 2010
• Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitusThanos Mergoupis — 2008
• Association between One-Hour Post-Load Plasma Glucose Levels and Vascular Stiffness in Essential Hypertension曉 村松, 範義 角田, 清英 吉田 — 2012
• Lower incidence of recorded cardiovascular outcomes in patients with type 2 diabetes using insulin aspart vs. those on human regular insulin: observational evidence from general practicesWolfgang Rathmann, Karel Kostev — 2013
• Nateglinide and Acarbose Are Comparably Effective Reducers of Postprandial Glycemic Excursions in Chinese Antihyperglycemic Agent–Naive Subjects with Type 2 DiabetesRoman O. Grigoriev, Alejandro Garzón — 2013
• Insulin as an Early Treatment for Type 2 DiabetesB.C. Elmer, M.E. Mazo — 2013
• Physical Activity is Strongly Inversely Related To Post-Challenge Plasma Glucose and Glycemic Spikes in a Risk Population for Type 2 DiabetesZuhairah Hasan, Ridhawati Zakaria — 2013
• Risikofaktorenmanagement bei koronarer HerzerkrankungEphraim B. Winzer, Gerhard Schüler — 2014
• Cardiometabolic Risk in Hyperlipidemic Men and WomenValerie E. Lee, Julia B. Smith, Tamara E. Perry — 2016

Related papers

• 059 Secondary progressive MS in the UK: a prospective cohort studyKatharine Harding, Fady Joseph, Trevor Pickersgill — 2022
• Detecting diabetes and impaired glucose tolerance in patients with atherosclerotic peripheral arterial disease.F. C. Green, Rosie Levison, D. J. Newton — 2012
• Prevalence of new and known diabetes mellitus, impaired glucose tolerance, and impaired fasting glucose.Chris Florkowski, D W Beaven — 2007
• Atherosclerotic Risk Factors in Japanese Subjects With Isolated Impaired Fasting Glucose and Those With Isolated Impaired Glucose Tolerance According to 1997 and 2003 American Diabetes Association CriteriaShinya Morita, Soji Kasayama, Michio Otsuki — 2006
• Impaired fasting glucose and impaired glucose tolerance - lack of agreement between the two categories in a North Indian population.Abdul Hamid Zargar, Shariq Rashid Masoodi, Ajaz Kariem Khan — 2001
• The utility of fasting plasma glucose to identify impaired glucose metabolism in women with polycystic ovary syndromeJana Vrbíková, Martin Hill, Michael Fanta — 2014
• Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose.Ralph A. DeFronzo, Muhammad Abdul‐Ghani — 2011
• Prevalence of abnormal glucose metabolism in patients with coronary artery disease:A clinical analysisHaiyan Li — 2010
• Analysis of the clincal characteristics of increased fasting glucose and increased postchallenge glucoseWei Ren — 2005